Sponsorizzato
Ivermectin Headlines Again as U.S. Faces Health Policy Shifts
In 2025, ivermectin continues to make headlines as U.S. healthcare policy undergoes significant transformation. Amid agency restructuring, budget adjustments, and rising public discourse around drug affordability, ivermectin has resurfaced in discussions around medical freedom, alternative therapies, and national health strategy. As policymakers grapple with healthcare reform, the...
0 Commenti 0 condivisioni 1K Views 0 Anteprima
Sponsorizzato
Sponsorizzato
Sponsorizzato